“…11,13-16 BT has been studied or described in humans in many varied clinical scenarios such as laparotomy, 17,18 emergency and elective surgery, [17][18][19][20] hematologic and colorectal malignancies, 21,22 intestinal obstruction, 23,24 burns, 25 inflammatory bowel disease, 26,27 aortic aneurysm repair, 28 liver resection, 29,30 obstructive jaundice, 31,32 trauma, [33][34][35] pediatric small bowel transplant, 36 and surgical neonates and infants receiving PN, 37 among others. Several of these studies also related BT to increased morbidity, [17][18][19]21,[23][24][25][26]28,29,31,33,34,37 but others did not. 20,22,27,30,32,35,36 A commonly proposed promotional mechanism of BT is physical damage to the barrier function of the intestinal mucosa leading to increased permeability.…”